Education
About Us
Working with TipRanks
Follow Us
Stimcell Energetics (STME)
OTHER OTC:STME
STME Stock Chart & Stats
$0.30
-$0.03(-6.00%)
At close: 4:00 PM EST
$0.30
-$0.03(-6.00%)
Day’s Range― - ―
52-Week Range$0.22 - $0.48
Previous CloseN/A
Volume500.00
Average Volume (3M)153.00
Market Cap
$6.27M
Enterprise Value$5.93M
Total Cash (Recent Filing)$46.16K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-5.09
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding20,891,272
10 Day Avg. Volume169
30 Day Avg. Volume153
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-7.64
Price to Sales (P/S)0.00
P/FCF Ratio-67.25
Enterprise Value/Market Cap0.95
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-12.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Stimcell Energetics News
STME FAQ
What was Stimcell Energetics’s price range in the past 12 months?
Stimcell Energetics lowest stock price was $0.22 and its highest was $0.48 in the past 12 months.
What is Stimcell Energetics’s market cap?
Stimcell Energetics’s market cap is $6.27M.
When is Stimcell Energetics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stimcell Energetics’s earnings last quarter?
Currently, no data Available
Is Stimcell Energetics overvalued?
According to Wall Street analysts Stimcell Energetics’s price is currently Overvalued.
Does Stimcell Energetics pay dividends?
Stimcell Energetics does not currently pay dividends.
What is Stimcell Energetics’s EPS estimate?
Stimcell Energetics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stimcell Energetics have?
Stimcell Energetics has 20,891,272 shares outstanding.
What happened to Stimcell Energetics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Stimcell Energetics?
Currently, no hedge funds are holding shares in STME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stimcell Energetics
StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Technical Analysis
Ownership Overview
19.93%
Insiders
― Other Institutional Investors
80.07% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---